Faculty: Nicole Mittmann, PhD

Nicole Mittmann, PhDNicole Mittmann, PhD
Assistant Professor, Pharmacology & Toxicology
Chief Research Officer, Cancer Care Ontario

General Research Areas: Pharmacoeconomics, pharmacoepidemiology, drug safety and health services research.

PubMed

Selected Publications:

1.        Hassan SH, Seung SJS, Cheung MC, Fraser G, Kuriakose B, Trambitis C, Mittmann N.  Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario.  Current Oncology 2017; Feb 24(1): e50-e54.

2.        Naik H, Qui X, Brown M C, Mahler M, Ho H, Tiessen K, Thai H, Ho v, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Howell D, Seung SJ, Liu G, Mittmann N. Cancer Patients’ Willingness to Routinely Complete the EQ-5D Instrument at Clinic Visits. Journal of Population Therapeutics and Clinical Pharmacology 2016; 23(3): e196-e204.

3.        Naik H,  Howell D, Su J, Qiu X, Brown MC, Vennettilli A, Irwin M, Pat V, Solomon H, Wang T, Hon H, Eng L, Mahler M Thai H, Ho V, Xu W, Seung S, Mittmann N.   EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.  Patient-Patient Centered Outcomes Research 2016: Aug. 27 Epub.  doi:10.1007/s40271-016-0190-z.

4.        Kellar J, Von Heymann C, Zingaro J, Kuriakose B, Li A, Mittmann N. Private Payer Costs for Employees with Treatment Resistant Depression. American Journal of Pharmacy Benefits 2016; 8(4): e67-e75.

5.        Goyert N, Eeson G, Kagedan DJ, Behman R, Lemke M, Hallet J, Mittmann N, Law C, Karanicolas PJ, Coburn NG.  Pasireotide for the Prevention of Pancreatic Fistula following ancreaticoduodenectomy: A Cost-effectiveness Analysis.  Annals of Surgery. 2016 Aug 17 [Epub ahead of print].

6.        Mittmann N, de Oliveira C. Importance of cost estimates and cost studies. (editorial) Current Oncology 2016 Feb; 23(s1): s6.

7.        Mittmann N, Stout N, Lee P, Tosteson ANA, Trentham-Dietz A, Alagoz O, , Yaffe M. Total cost-effectiveness of mammography screening strategies.  Health Reports 2015; 26(12): 16-25.

8.        Yaffe M, Mittmann N, Lee P, Tosteson ANA, Trentham-Dietz A, Alagoz O, Stout N. Modelling mammography screening for breast cancer in the Canadian context - modification and testing of the a microsimulation model.  Health Reports 2015; 26(12): 38.

9.        Yaffe M, Mittmann N, Lee P, Tosteson ANA, Trentham-Dietz A, Alagoz O, Stout N.  Clinical outcomes of modelling mammography screening strategies.  Health Reports 2015; 26(12): 9-15. 

10.     Mittmann N, Seung SJ, Liu N, Porter J, Leighl N, Trudeau M, Evans W, Earle C. Homecare Utilization and Costs in Stage IV Lung Cancer: A Canadian Public Payer Experience.  Lung Cancer Management 2014; 3(6): 439-442.

11.     Mittmann N, Porter NJ, Rangrej J, Seung  SJ, Liu N, Saskin  R, Cheung MC, Leighl NB, Hoch JS, Trudeau M,  Evans  WK,  Dainty KN, DeAngelis C, Earle CC.   Health system costs for stage-specific breast cancer:  a population based approach. Current Oncology 2014; 21(6): 281-293.

12.     Mittmann N, Seung SJ, Liu N, Porter J, Saskin R, Hoch JS, Evans WK, Leighl NB, Trudeau M, Earle CC. Population based utilization of radiation therapy by a Canadian breast cancer cohort. Current Oncology 2014; 21(5): e715-717.

Contact:

Cancer Care Ontario
620 University Avenue
Toronto, ON M5G 2L7
Phone: 416-217-1233
FAX: 416-971-6888
E-mail: nicole.mittmann@sri.utoronto.ca (for Research/Study questions);
              nicole.mittmann@cancercare.on.ca

 

Back to Top